Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Stanulla

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Cancers|November 27, 2021
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved DiagnosticsPhilippe Chouvarine, Željko Antić, Jana Lentes, et al.
Blood Cancer Journal|June 28, 2020
Repurposing anthelmintic agents to eradicate resistant leukemiaCaterina Mezzatesta, Liridon Abduli, Anna Guinot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2008
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarrayNorihiko Kawamata, Seishi Ogawa, Martin Zimmermann, et al.
Pediatric Blood & Cancer|March 22, 2022
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype studyMarianne Helenius, Goda Vaitkeviciene, Jonas Abrahamsson, et al.
Blood|December 25, 2013
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALLArian van der Veer, Marketa Zaliova, Federica Mottadelli, et al.
Annals of Hematology|February 21, 2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemiaMaximilian Schieck, Jana Lentes, Kathrin Thomay, et al.
Haematologica|November 8, 2011
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeLutz Zeidler, Martin Zimmermann, Anja Möricke, et al.
Blood|March 21, 2022
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomesLidia M Fernández-Sevilla, Jaris Valencia, Paula Ortiz-Sánchez, et al.
Journal of Clinical Medicine|November 13, 2021
Genetic Variation in <i>ABCC4</i> and <i>CFTR</i> and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic LeukemiaThies Bartram, Peter Schütte, Anja Möricke, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Cancers|November 27, 2021
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved DiagnosticsPhilippe Chouvarine, Željko Antić, Jana Lentes, et al.
Blood Cancer Journal|June 28, 2020
Repurposing anthelmintic agents to eradicate resistant leukemiaCaterina Mezzatesta, Liridon Abduli, Anna Guinot, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2008
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarrayNorihiko Kawamata, Seishi Ogawa, Martin Zimmermann, et al.
Pediatric Blood & Cancer|March 22, 2022
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype studyMarianne Helenius, Goda Vaitkeviciene, Jonas Abrahamsson, et al.
Blood|December 25, 2013
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALLArian van der Veer, Marketa Zaliova, Federica Mottadelli, et al.
Annals of Hematology|February 21, 2020
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemiaMaximilian Schieck, Jana Lentes, Kathrin Thomay, et al.
Haematologica|November 8, 2011
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeLutz Zeidler, Martin Zimmermann, Anja Möricke, et al.
Blood|March 21, 2022
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomesLidia M Fernández-Sevilla, Jaris Valencia, Paula Ortiz-Sánchez, et al.
Journal of Clinical Medicine|November 13, 2021
Genetic Variation in <i>ABCC4</i> and <i>CFTR</i> and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic LeukemiaThies Bartram, Peter Schütte, Anja Möricke, et al.
Blood|May 2, 2009
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment responseMarc Remke, Stefan Pfister, Corinne Kox, et al.
Pageof 15